SCHEMBL13777733

SCHEMBL13777733

CCNC(=O)[C@@H](OCn1cnc2c(N)nc(C#CC3(O)CCCCC3C(C)(C)C)nc21)C(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13777711 0.92 ADORA3 (0.34) —
SCHEMBL10146196 0.89 ADORA3 (0.36) —
SCHEMBL3478695 0.86 MEN1 (0.32) —
SCHEMBL3478694 0.85 ADORA3 (0.37) —
SCHEMBL13777738 0.85 ADORA3 (0.36) —
SCHEMBL3478710 0.85 ADORA3 (0.36) —
SCHEMBL10146742 0.85 ADORA3 (0.36) —
SCHEMBL3478723 0.85 ADORA3 (0.36) —
SCHEMBL10146888 0.83 ADORA3 (0.37) —
SCHEMBL13777762 0.83 ADORA3 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170803-A1 ADJUNCTIVE TREATMENT OF BIOLOGICAL DISEASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-07-02 — — US disclosed
Send feedback